Clinical Trial Guidance Seeks To Improve Sex-Based Data
This article was originally published in The Gray Sheet
Executive Summary
Top goal of recent draft guidance is to increase the proportion of women participating in device trials. The document also emphasizes the types of analyses FDA will expect from device manufacturers to make the most of sex-specific data.
You may also be interested in...
Biotronik Starts First ICD Study Designed To Measure Sex-Specific Outcomes
BIO-LIBRA will study Biotronik ICDs and CRT-D devices in about 1,000 patients with non-ischemic cardiomyopathy. The investigators expect at least 40% of the subjects in BIO-LIBRA to be women.
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.